Clinical trial
Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Psoriasis
NCT01387815 is registered in ClinicalTrials.gov with AbbVie (prior sponsor, Abbott) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Psoriasis
- Lead sponsor
- AbbVie (prior sponsor, Abbott)
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 16, 2011
- Completion date
- June 29, 2018
- Enrollment
- 662 (actual)
- Sites
- 36
Conditions
As the registry lists them; a condition with its own page is linked.